Pre-operative Nutrition for Inflammatory Bowel Disease
Trial Summary
What is the purpose of this trial?
This study aims to determine if improved risk stratification tools and interventions to mitigate malnutrition reduce postoperative risk in patients undergoing elective or emergent resection surgery for inflammatory bowel disease (IBD), and if adding immune modulation nutrition improves surgical outcomes. The primary objective is to assess whether preoperative malnutrition screening and intervention minimize postoperative complications. The secondary objective is to evaluate whether immune modulation nutrition in the peri-operative period decreases length of stay and major complications.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Ensure Surgery Immunonutrition shakes for pre-operative nutrition in patients with Inflammatory Bowel Disease?
Research suggests that preoperative nutrition, including immunonutrition, can improve nutritional status and reduce complications in patients undergoing surgery for inflammatory bowel disease. While specific data on Ensure Surgery Immunonutrition shakes is not provided, similar treatments have shown benefits in reducing postoperative complications.12345
Is pre-operative nutrition, like Ensure Surgery Immunonutrition shakes, safe for humans?
How does pre-operative nutrition differ from other treatments for inflammatory bowel disease?
Pre-operative nutrition for inflammatory bowel disease is unique because it focuses on improving nutritional status before surgery, which can reduce complications and disease severity. Unlike standard drug treatments, this approach uses oral or enteral nutrition (feeding through the digestive tract) and, in severe cases, parenteral nutrition (feeding through a vein) to address malnutrition, a common issue in IBD patients.13456
Research Team
Jennifer Katz, MD
Principal Investigator
NYU Langone Health
Eligibility Criteria
This trial is for patients with inflammatory bowel disease (IBD) who are scheduled for elective resection surgery. Participants should be screened for malnutrition and willing to follow a nutrition plan provided by specialists.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Nutrition Intervention
Participants receive nutrition-focused visits and interventions to mitigate malnutrition prior to surgery
Surgery and Immediate Post-operative Care
Participants undergo elective or emergent resection surgery and receive immediate post-operative care
Follow-up
Participants are monitored for safety and effectiveness after surgery, including assessment of postoperative complications
Treatment Details
Interventions
- Ensure Surgery Immunonutrition shakes
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor